2020-27241. Bulk Manufacturer of Controlled Substances Application: Johnson Matthey, Inc.  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    Johnson Matthey, Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 9, 2021. Such persons may also file a written request for a hearing on the application on or before February 9, 2021.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.33(a), this is notice that on November 2, 2020, Johnson Matthey, Inc., 2003 Nolte Drive West Deptford, New Jersey 08066-1742, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s):

    Controlled substanceDrug codeSchedule
    Gamma Hydroxybutyric Acid2010I
    Marihuana7360I
    Tetrahydrocannabinols7370I
    Dihyromorphine9145I
    Difenoxin9168I
    Amphetamine1100II
    Methamphetamine1105II
    Lisdexamfetamine1205II
    Methylphenidate1724II
    Nabilone7379II
    Norfentanyl8366II
    Cocaine9041II
    Codeine9050II
    Dihydrocodeine9120II
    Oxycodone9143II
    Hydromorphone9150II
    Diphenoxylate9170II
    Ecgonine9180II
    Hydrocodone9193II
    Levorphanol9220II
    Meperidine9230II
    Methadone9250II
    Methadone intermediate9254II
    Morphine9300II
    Thebaine9333II
    Opium tincture9630II
    Oxymorphone9652II
    Noroxymorphone9668II
    Alfentanil9737II
    Remifentanil9739II
    Sufentanil9740II
    Tapentadol9780II
    Fentanyl9801II

    The company plans to bulk manufacture the listed controlled substances for the internal use intermediates or for sale to its customers. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.

    Start Signature

    William T. McDermott,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2020-27241 Filed 12-10-20; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
12/11/2020
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2020-27241
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 9, 2021. Such persons may also file a written request for a hearing on the application on or before February 9, 2021.
Pages:
80159-80159 (1 pages)
Docket Numbers:
Docket No. DEA-752
PDF File:
2020-27241.pdf